Health Care & Life Sciences » Biotechnology | Kang Stem Biotech Co. Ltd.

Kang Stem Biotech Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
-
-
5,754,141.00
8,300,375.00
10,917,959.00
Depreciation, Depletion & Amortization
-
-
685,644.00
838,392.00
1,065,211.00
Other Funds
-
-
-
239,065.60
15,926.60
Funds from Operations
-
-
4,372,230.80
7,957,608.10
11,392,921.30
Changes in Working Capital
-
-
549,658.00
382,978.00
687,642.00
Net Operating Cash Flow
2,626,615.20
3,670,471.40
3,822,572.80
7,574,630.10
12,080,563.30
Capital Expenditures
976,083.80
275,111.00
1,037,439.40
1,675,730.70
8,585,747.40
Sale of Fixed Assets & Businesses
-
-
200.00
-
845,124.00
Purchase/Sale of Investments
3,858,778.50
3,161,448.50
10,839,461.00
25,046,473.80
20,925,149.30
Net Investing Cash Flow
4,395,194.00
3,295,465.70
12,058,912.70
26,722,204.50
7,310,153.60
Issuance/Reduction of Debt, Net
39,050.00
66,600.00
9,666,547.00
29,709,814.40
3,305,000.00
Net Financing Cash Flow
7,917,505.20
66,600.00
21,489,927.00
30,170,015.40
6,679,532.70
Net Change in Cash
895,696.00
441,605.80
5,608,441.60
4,126,819.20
1,908,793.50
Free Cash Flow
3,574,947.00
3,940,609.20
4,559,054.40
8,935,414.40
20,200,818.00
Net Assets from Acquisitions
-
-
-
-
5,874,372.30
Other Sources
553,551.90
567,579.60
-
-
-
Change in Capital Stock
7,956,555.20
-
11,823,380.00
699,266.60
3,358,606.10
Exchange Rate Effect
-
-
-
-
329.50
Other Uses
113,883.60
158,451.50
182,212.30
-
-

About Kang Stem Biotech Co.

View Profile
Address
17th Floor, Shinan Building
Seoul SL 06179
Korea, Republic Of
Employees -
Website http://www.kangstem.com
Updated 09/14/2018
KangStem Biotech Co., Ltd. develops and commercializes stem cell therapies. Its therapies include next generation and gene-loaded stem cell. In addition, it also provides contract research and manufacturing services and drug screening services.